Alembic Pharmaceuticals

BSE: 533573 | NSE: APLLTD | ISIN: INE901L01018 | SECTOR: Biotechnology & Drugs

991.00

-6.90 (-0.69%)
26 Apr 2024, 03:29 PM IST

Key Metrics

Influencer Count

-

Simple Moving Averages

DaysBSENSE

5945.72949.02
10966.95968.55
20976.38977.94
50989.69990.60
100909.79910.30
300828.21828.58

News

Company Description

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others.

Company Officers